Literature DB >> 18078863

Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Susan Sam1, Yeon-Ah Sung, Richard S Legro, Andrea Dunaif.   

Abstract

Hyperandrogenemia and insulin resistance are heritable traits in sisters of women with polycystic ovary syndrome (PCOS). Hyperandrogenemia also appears to be the male reproductive phenotype; however, it is less clear whether male relatives are at risk for the metabolic disorders associated with PCOS. In this study, we tested the hypothesis that brothers of women with PCOS have defects in insulin action and/or secretion. Twenty-three non-Hispanic white brothers of women with PCOS and 23 non-Hispanic white control men of comparable age matched for body mass index underwent a modified frequently sampled intravenous glucose tolerance test. Parameters of insulin sensitivity and secretion were determined using minimal-model Bergman protocol. Disposition index was significantly decreased (2540 [1080, 3172] vs 2901 [2096, 4487], P = .009) independent of a family history of diabetes mellitus, and glucose effectiveness was significantly increased (2.4 [1.9, 2.7] vs 2.0 [1.8, 2.2], P = .02) in brothers compared with control men. We conclude that brothers of women with PCOS have evidence for pancreatic beta-cell dysfunction and may be at increased risk for type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18078863      PMCID: PMC2710887          DOI: 10.1016/j.metabol.2007.08.010

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  48 in total

Review 1.  Familial polycystic ovarian disease.

Authors:  J R Givens
Journal:  Endocrinol Metab Clin North Am       Date:  1988-12       Impact factor: 4.741

2.  Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness.

Authors:  C McDonald; A Dunaif; D T Finegood
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

3.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

4.  Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples.

Authors:  M Modan; M I Harris; H Halkin
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

Review 5.  Polycystic ovary syndrome: syndrome XX?

Authors:  Susan Sam; Andrea Dunaif
Journal:  Trends Endocrinol Metab       Date:  2003-10       Impact factor: 12.015

6.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

7.  Impaired glucose effectiveness in patients with polycystic ovary syndrome.

Authors:  T Falcone; A B Little; D Morris
Journal:  Hum Reprod       Date:  1992-08       Impact factor: 6.918

8.  The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1994-04       Impact factor: 9.461

Review 9.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

Authors:  R N Bergman
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  23 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

Review 2.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

3.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

4.  Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.

Authors:  Laura C Torchen; Naomi R Fogel; Wendy J Brickman; Rodis Paparodis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

5.  The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size.

Authors:  C M Ackerman; L P Lowe; H Lee; F Chen; E Hughes; P Cholod; A R Dyer; M G Hayes; B E Metzger; W L Lowe; M Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

6.  Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.

Authors:  Richard S Legro; Rebecca L Roller; William C Dodson; Christina M Stetter; Allen R Kunselman; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

8.  High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.

Authors:  Andrea D Coviello; Susan Sam; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

9.  Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.

Authors:  Assel Biyasheva; Richard S Legro; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

10.  Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.

Authors:  Sarah C Kent; Carol L Gnatuk; Allen R Kunselman; Laurence M Demers; Peter A Lee; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.